These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9443530)

  • 1. A two-separate-motivational-systems hypothesis of opioid addiction.
    Bechara A; Nader K; van der Kooy D
    Pharmacol Biochem Behav; 1998 Jan; 59(1):1-17. PubMed ID: 9443530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone attenuates the opioid withdrawal and vulnerability to relapse to heroin seeking in rodents.
    de Guglielmo G; Kallupi M; Scuppa G; Demopulos G; Gaitanaris G; Ciccocioppo R
    Psychopharmacology (Berl); 2017 Jan; 234(2):223-234. PubMed ID: 27714428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A test of the opponent-process theory of motivation using lesions that selectively block morphine reward.
    Vargas-Perez H; Ting-A-Kee RA; Heinmiller A; Sturgess JE; van der Kooy D
    Eur J Neurosci; 2007 Jun; 25(12):3713-8. PubMed ID: 17610590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence.
    Walker BM; Koob GF
    Neuropsychopharmacology; 2008 Feb; 33(3):643-52. PubMed ID: 17473837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRF2 Receptor Deficiency Eliminates the Long-Lasting Vulnerability of Motivational States Induced by Opiate Withdrawal.
    Morisot N; Rouibi K; Contarino A
    Neuropsychopharmacology; 2015 Jul; 40(8):1990-2000. PubMed ID: 25672976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurobiology of Opioid Addiction: Opponent Process, Hyperkatifeia, and Negative Reinforcement.
    Koob GF
    Biol Psychiatry; 2020 Jan; 87(1):44-53. PubMed ID: 31400808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered motivation and learning following opiate withdrawal: evidence for prolonged dysregulation of reward processing.
    Harris GC; Aston-Jones G
    Neuropsychopharmacology; 2003 May; 28(5):865-71. PubMed ID: 12736632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different neural systems mediate morphine reward and its spontaneous withdrawal aversion.
    Vargas-Perez H; Ting-A-Kee R; van der Kooy D
    Eur J Neurosci; 2009 May; 29(10):2029-34. PubMed ID: 19453632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of aripiprazole on operant responding for a natural reward after psychostimulant withdrawal in rats.
    Schwabe K; Koch M
    Psychopharmacology (Berl); 2007 Apr; 191(3):759-65. PubMed ID: 16953383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction.
    Mas-Nieto M; Pommier B; Tzavara ET; Caneparo A; Da Nascimento S; Le Fur G; Roques BP; Noble F
    Br J Pharmacol; 2001 Apr; 132(8):1809-16. PubMed ID: 11309253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cues conditioned to withdrawal and negative reinforcement: Neglected but key motivational elements driving opioid addiction.
    Pantazis CB; Gonzalez LA; Tunstall BJ; Carmack SA; Koob GF; Vendruscolo LF
    Sci Adv; 2021 Apr; 7(15):. PubMed ID: 33827822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociating Motivational From Physiological Withdrawal in Alcohol Dependence: Role of Central Amygdala κ-Opioid Receptors.
    Kissler JL; Walker BM
    Neuropsychopharmacology; 2016 Jan; 41(2):560-7. PubMed ID: 26105136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultra-low-dose naltrexone suppresses rewarding effects of opiates and aversive effects of opiate withdrawal in rats.
    Olmstead MC; Burns LH
    Psychopharmacology (Berl); 2005 Sep; 181(3):576-81. PubMed ID: 16010543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral interactions of pain and reward and their relevance for chronic pain.
    Becker S; Gandhi W; Schweinhardt P
    Neurosci Lett; 2012 Jun; 520(2):182-7. PubMed ID: 22440855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motivational effects of opioids: evidence on the role of endorphins in mediating reward or aversion.
    Stolerman IP
    Pharmacol Biochem Behav; 1985 Nov; 23(5):877-81. PubMed ID: 3909169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reinforcement and the combination of effects: summary of a theory of opiate addiction.
    McAuliffe WE; Gordon RA
    NIDA Res Monogr; 1980 Mar; 30():137-41. PubMed ID: 6779170
    [No Abstract]   [Full Text] [Related]  

  • 17. Understanding how opioids contribute to reward and analgesia.
    Fields HL
    Reg Anesth Pain Med; 2007; 32(3):242-6. PubMed ID: 17543821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocannabinoid system and opioid addiction: behavioural aspects.
    Fattore L; Deiana S; Spano SM; Cossu G; Fadda P; Scherma M; Fratta W
    Pharmacol Biochem Behav; 2005 Jun; 81(2):343-59. PubMed ID: 15935459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human dependence on tobacco and opioids: common factors.
    Henningfield JE; Griffiths RR; Jasinki DR
    NIDA Res Monogr; 1981 Jul; 37():210-34. PubMed ID: 6798460
    [No Abstract]   [Full Text] [Related]  

  • 20. Opiate reinforcement processes: re-assembling multiple mechanisms.
    Bozarth MA
    Addiction; 1994 Nov; 89(11):1425-34. PubMed ID: 7841852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.